AtriCure Inc (ATRC) Stock
Fundamentals
Recent news

Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?
ATRC

AtriCure CTO Sells 3,657 Shares
AtriCure CTO Sells 3,657 Shares
ATRC

Do Options Traders Know Something About AtriCure Stock We Don't?
Do Options Traders Know Something About AtriCure Stock We Don't?
ATRC

AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue?
AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue?
ATRC
Technicals
Analyst Ratings
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of -$0.02 for this quarter. The company has not yet shared when it is announcing earnings.
% positive news of 10 articles
published over the past 14 days
Latest news

Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?
ATRC

AtriCure CTO Sells 3,657 Shares
AtriCure CTO Sells 3,657 Shares
ATRC

Do Options Traders Know Something About AtriCure Stock We Don't?
Do Options Traders Know Something About AtriCure Stock We Don't?
ATRC

AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue?
AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue?
ATRC

Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?
Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?
ATRC

AtriCure to Participate in the 2026 Wells Fargo Health Care Conference
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference
ATRC

AtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel Growth
AtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel Growth
ATRC

Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors
Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors
ATRC

An AtriCure Director Sold $905,000 in Stock. Here's How to Read It
An AtriCure Director Sold $905,000 in Stock. Here's How to Read It
ATRC

AtriCure to Participate at Upcoming Investor Conferences
AtriCure to Participate at Upcoming Investor Conferences
ATRC
About AtriCure Inc
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael H. Carrel | CEO, President & Director | 1971 |
| Ms. Angela L. Wirick | Chief Financial Officer | 1978 |
| Mr. Douglas J. Seith | Chief Operating Officer | 1966 |
| Mr. Salvatore Privitera J.D. | Chief Technical Officer | 1967 |
| Mr. Justin J. Noznesky | Chief Marketing & Strategy Officer | 1978 |
| Dr. Vinayak Doraiswamy Ph.D. | Chief Scientific Officer | 1973 |
| Mr. Karl S. Dahlquist CCEP, J.D. | Chief Legal Officer | 1971 |
| Valerie Storch-Willhaus | Vice President of Corporate Marketing & Communications | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
Technicals
What the experts say
4 Wall Street Analyst Ratings
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +0.4 | +7.6 | -18.2 | +6.1 | ||||||||
| 2022 | -8.1 | +5.2 | -5.6 | -21.3 | -25.8 | +2.3 | +20.5 | -6.6 | -9.1 | +5.3 | +6.1 | -3.4 |
| 2023 | -3.5 | -12.8 | +6.8 | +5.7 | -0.3 | +7.8 | +13.1 | -19.7 | -4.2 | -19.9 | +1.3 | -2.4 |
| 2024 | -3.6 | +3.8 | -16.2 | -17.1 | -9.0 | +1.6 | +3.1 | |||||
| 2025 | +4.3 | |||||||||||
| 2026 | -0.1 | -15.1 | -7.8 | -0.7 | -4.7 | +5.7 | +27.0 | +24.9 | +19.3 |



